Last reviewed · How we verify
NCT05002634
Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer
NA trial testing undenatured collagen type II (UCII) supplement in Health, Subjective in 60 participants. Status unknown.
30 June 2022
Quick facts
| Lead sponsor | Chulalongkorn University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 5 August 2021 |
| Primary completion | 30 June 2022 |
| Estimated completion | 31 July 2022 |
Drugs / interventions tested
- undenatured collagen type II (UCII) supplement
Conditions studied
- Health, Subjective — all drugs for Health, Subjective →
Sponsor
Chulalongkorn University
Who can join
Adults 20 to 60, any sex, with Health, Subjective. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05002634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health, Subjective
Currently open trials in the same condition.
- NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
- NCT06829485 — Florida Community-Engaged Research Alliance (FL-CEAL) · NA · recruiting
- NCT06392880 — Comparison of Floss Band Application and Mulligan Mobilization · NA · recruiting
- NCT06575907 — Health, Functioning, Work, and Experiences of Social and Health Services of Persons With Stroke · active not recruiting
- NCT05760001 — The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being · NA · active not recruiting
Other Chulalongkorn University trials
Trials by the same sponsor.
- NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
- NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
- NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
- NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
- NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05002634 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
- Last refreshed: 12 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05002634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing